Dermapharm Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Dermapharm Holding SE
Access all reports
Dermapharm Holding SE engages in the off-patent branded pharmaceuticals business in Germany and internationally. It offers products for the treatment of inflammatory skin diseases, allergic reactions, disorders of the gastrointestinal tract, cardiovascular disorders and metabolic diseases. Furthermore, it offers active pharmaceutical ingredients that are used for further manufacturing of prescription drugs.
Key slides for Dermapharm Holding SE
Q2 2023
Dermapharm Holding SE
Q4 2023
Dermapharm Holding SE
Latest articles
Larry Page: The Mastermind Behind Google
Explore the journey of Larry Page from a tech-savvy youth to co-founding Google and leading Alphabet.
24 Apr 2024
Mark Leonard: The Mysterious Brain Behind Constellation Software
Information about Mark Leonard is scarce, and one of the only ways to “get to know” him is through his shareholder letters. Join us in an attempt to do so.
24 Apr 2024
Sundar Pichai: CEO of Alphabet and Google
Explore Sundar Pichai's improbable journey from Chennai, India, to becoming one of the most powerful individuals on the planet.
19 Apr 2024
Ticker symbol
Country
🇩🇪 Germany